Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group. García-Marco JA, et al. Among authors: de paz arias r. Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19. Haematologica. 2019. PMID: 30890600 Free PMC article.
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, García-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF; Spanish Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Groups. Paiva B, et al. Blood. 2016 Apr 14;127(15):1896-906. doi: 10.1182/blood-2015-08-665679. Epub 2016 Jan 11. Blood. 2016. PMID: 26755711 Free article. Clinical Trial.
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
Adès L, Girshova L, Doronin VA, Díez-Campelo M, Valcárcel D, Kambhampati S, Viniou NA, Woszczyk D, De Paz Arias R, Symeonidis A, Anagnostopoulos A, Munhoz EC, Platzbecker U, Santini V, Fram RJ, Yuan Y, Friedlander S, Faller DV, Sekeres MA. Adès L, et al. Among authors: de paz arias r. Blood Adv. 2022 Sep 13;6(17):5132-5145. doi: 10.1182/bloodadvances.2022007334. Blood Adv. 2022. PMID: 35728048 Free PMC article. Clinical Trial.
Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak.
Ramírez-López A, Lázaro Del Campo P, Humala K, De la Cruz Benito B, Sánchez-Vadillo I, López de la Guía A, de Paz Arias R, Jiménez-Yuste V, Canales M. Ramírez-López A, et al. Among authors: de paz arias r. Leuk Lymphoma. 2021 Aug;62(8):2034-2036. doi: 10.1080/10428194.2021.1886291. Epub 2021 Feb 28. Leuk Lymphoma. 2021. PMID: 33645389 No abstract available.
No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19.
Lázaro Del Campo P, de Paz Arias R, Ramírez López A, de la Cruz Benito B, Humala Barbier K, Sánchez Vadillo I, López de la Guía A, de Soto Álvarez T, Jiménez Yuste V, Canales Albendea M. Lázaro Del Campo P, et al. Among authors: de paz arias r. Transfus Apher Sci. 2020 Dec;59(6):102921. doi: 10.1016/j.transci.2020.102921. Epub 2020 Aug 24. Transfus Apher Sci. 2020. PMID: 32928663 Free PMC article.
Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid.
Lázaro Del Campo P, Ramírez López A, de la Cruz Benito B, de Paz Arias R, de Soto Álvarez T, Sánchez Vadillo I, Humala Barbier K, García Pérez E, Dos Santos Ortas A, López de la Guía A, Gasior Kabat M, Baltasar Tello P, Jiménez Yuste V, Canales Albendea M. Lázaro Del Campo P, et al. Among authors: de paz arias r. Expert Rev Hematol. 2021 Jan;14(1):1-5. doi: 10.1080/17474086.2021.1858789. Epub 2020 Dec 12. Expert Rev Hematol. 2021. PMID: 33280467 No abstract available.
Nutritional intervention in oncohematological patient.
Gómez-Candela C, Canales Albendea MA, Palma Milla S, de Paz Arias R, Díaz Gómez J, Rodríguez-Durán D, Villarino-Sanz M, Arribas Hortigüela L, Burgos Peláez R. Gómez-Candela C, et al. Among authors: de paz arias r. Nutr Hosp. 2012 May-Jun;27(3):669-80. doi: 10.3305/nh.2012.27.3.5863. Nutr Hosp. 2012. PMID: 23114930 Free article. Review. English, Spanish.
[Nutrition in the surgical patient: immunonutrition].
Culebras-Fernández JM, de Paz-Arias R, Jorquera-Plaza F, García de Lorenzo A. Culebras-Fernández JM, et al. Among authors: de paz arias r. Nutr Hosp. 2001 May-Jun;16(3):67-77. Nutr Hosp. 2001. PMID: 11475680 Review. Spanish.
A new method for surgical treatment of the short bowel syndrome.
Tamazashvili TS, Popova TS, Titova GP, Platonova GA, Tropskaya NS, de Paz-Arias R, González-Gallego J, Vasiljev VA, Culebras JM. Tamazashvili TS, et al. Among authors: de paz arias r. Nutr Hosp. 2001 Jul-Aug;16(4):133-9. Nutr Hosp. 2001. PMID: 11676184
12 results